AMENDED AND RESTATED DEVELOPMENT AND LICENSE AGREEMENT GENENTECH, INC. AND SEATTLE GENETICS, INC.Development and License Agreement • March 6th, 2001 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • Washington
This Amended and Restated Development and License Agreement (the "Agreement") is made effective as of March 2, 2001 (the "Agreement") by and between Genentech, Inc. ("GNE"), a Delaware corporation with its principal office at 1 DNA Way, South San Francisco, California 94080 and Seattle Genetics, Inc. ("SG"), a Delaware corporation with its principal office at 22215 26th Avenue SE, Bothell, Washington 98021, each on behalf of itself and its Affiliates. GNE and SG are sometimes referred to herein individually as a "Party" and collectively as the "Parties," and references to "GNE" and "SG" shall include their respective Affiliates.
COLLABORATION AGREEMENTCollaboration Agreement • March 6th, 2001 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • New York
THIS COLLABORATION AGREEMENT ("Agreement") is made and entered into effective as of February 2, 2001 (the "Effective Date"), by and between SEATTLE GENETICS, INC., having principal offices at 22215 26th Avenue S.E., Suite 3000, Bothell, WA 98021 ("Seattle Genetics") and MEDAREX, INC., having principal offices at 707 State Road, Suite 206, Princeton, New Jersey 08540-1437, on behalf of itself and its wholly owned subsidiary, GENPHARM INTERNATIONAL, INC., with principal offices at 2350 Qume Drive, San Jose, California 95131 (collectively, "Medarex"). Seattle Genetics and Medarex each may be referred to herein individually as a "Party," or collectively as the "Parties."
SEATTLE GENETICS, INC. COMMON STOCK PURCHASE AGREEMENT Dated as of March 5, 2001Common Stock Purchase Agreement • March 6th, 2001 • Seattle Genetics Inc /Wa • Services-commercial physical & biological research • Washington
This Common Stock Purchase Agreement (this "Agreement") is made as of March 5, 2001 between Seattle Genetics, Inc., a Delaware corporation with its principal office at 22215 26th Avenue SE, Suite 3000, Bothell, WA 98021 (the "Company"), and Genentech, Inc., a Delaware corporation with its principal office at 1 DNA Way, South San Francisco, CA 94080 (the "Purchaser").
